These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Survival of melanoma patients treated with targeted therapy and immunotherapy after systematic upfront control of brain metastases by radiosurgery. Gaudy-Marqueste C; Dussouil AS; Carron R; Troin L; Malissen N; Loundou A; Monestier S; Mallet S; Richard MA; Régis JM; Grob JJ Eur J Cancer; 2017 Oct; 84():44-54. PubMed ID: 28783540 [TBL] [Abstract][Full Text] [Related]
5. Real-life data for first-line combination immune-checkpoint inhibition and targeted therapy in patients with melanoma brain metastases. Hilbers ML; Dimitriou F; Lau P; Bhave P; McArthur GA; Zimmer L; Kudura K; Gérard CL; Levesque MP; Michielin O; Dummer R; Cheng PF; Mangana J Eur J Cancer; 2021 Oct; 156():149-163. PubMed ID: 34454317 [TBL] [Abstract][Full Text] [Related]
6. Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients. Amaral T; Kiecker F; Schaefer S; Stege H; Kaehler K; Terheyden P; Gesierich A; Gutzmer R; Haferkamp S; Uttikal J; Berking C; Rafei-Shamsabadi D; Reinhardt L; Meier F; Karoglan A; Posch C; Gambichler T; Pfoehler C; Thoms K; Tietze J; Debus D; Herbst R; Emmert S; Loquai C; Hassel JC; Meiss F; Tueting T; Heinrich V; Eigentler T; Garbe C; Zimmer L; J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32221017 [TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitor, or conventional chemotherapy. Ahmed KA; Abuodeh YA; Echevarria MI; Arrington JA; Stallworth DG; Hogue C; Naghavi AO; Kim S; Kim Y; Patel BG; Sarangkasiri S; Johnstone PA; Sahebjam S; Khushalani NI; Forsyth PA; Harrison LB; Yu M; Etame AB; Caudell JJ Ann Oncol; 2016 Dec; 27(12):2288-2294. PubMed ID: 27637745 [TBL] [Abstract][Full Text] [Related]
8. Timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery. Qian JM; Yu JB; Kluger HM; Chiang VL Cancer; 2016 Oct; 122(19):3051-8. PubMed ID: 27285122 [TBL] [Abstract][Full Text] [Related]
9. Stereotactic radiosurgery combined with targeted/ immunotherapy in patients with melanoma brain metastasis. Hadi I; Roengvoraphoj O; Bodensohn R; Hofmaier J; Niyazi M; Belka C; Nachbichler SB Radiat Oncol; 2020 Feb; 15(1):37. PubMed ID: 32059731 [TBL] [Abstract][Full Text] [Related]
10. Impact of radiation, systemic therapy and treatment sequencing on survival of patients with melanoma brain metastases. Rauschenberg R; Bruns J; Brütting J; Daubner D; Lohaus F; Zimmer L; Forschner A; Zips D; Hassel JC; Berking C; Kaehler KC; Utikal J; Gutzmer R; Terheyden P; Meiss F; Rafei-Shamsabadi D; Kiecker F; Debus D; Dabrowski E; Arnold A; Garzarolli M; Kuske M; Beissert S; Löck S; Linn J; Troost EGC; Meier F Eur J Cancer; 2019 Mar; 110():11-20. PubMed ID: 30739835 [TBL] [Abstract][Full Text] [Related]
11. Survival of melanoma patients with brain metastases treated with ipilimumab and stereotactic radiosurgery. Tazi K; Hathaway A; Chiuzan C; Shirai K Cancer Med; 2015 Jan; 4(1):1-6. PubMed ID: 25164960 [TBL] [Abstract][Full Text] [Related]
12. Stereotactic radiosurgery and immunotherapy in melanoma brain metastases: Patterns of care and treatment outcomes. Gabani P; Fischer-Valuck BW; Johanns TM; Hernandez-Aya LF; Keller JW; Rich KM; Kim AH; Dunn GP; Robinson CG; Chicoine MR; Huang J; Abraham CD Radiother Oncol; 2018 Aug; 128(2):266-273. PubMed ID: 29960685 [TBL] [Abstract][Full Text] [Related]
13. The combination of stereotactic radiosurgery with immune checkpoint inhibition or targeted therapy in melanoma patients with brain metastases: a retrospective study. Martins F; Schiappacasse L; Levivier M; Tuleasca C; Cuendet MA; Aedo-Lopez V; Gautron Moura B; Homicsko K; Bettini A; Berthod G; Gérard CL; Wicky A; Bourhis J; Michielin O J Neurooncol; 2020 Jan; 146(1):181-193. PubMed ID: 31836957 [TBL] [Abstract][Full Text] [Related]
14. Radiation necrosis with stereotactic radiosurgery combined with CTLA-4 blockade and PD-1 inhibition for treatment of intracranial disease in metastatic melanoma. Fang P; Jiang W; Allen P; Glitza I; Guha N; Hwu P; Ghia A; Phan J; Mahajan A; Tawbi H; Li J J Neurooncol; 2017 Jul; 133(3):595-602. PubMed ID: 28500560 [TBL] [Abstract][Full Text] [Related]
15. Impact on overall survival of the combination of BRAF inhibitors and stereotactic radiosurgery in patients with melanoma brain metastases. Wolf A; Zia S; Verma R; Pavlick A; Wilson M; Golfinos JG; Silverman JS; Kondziolka D J Neurooncol; 2016 May; 127(3):607-15. PubMed ID: 26852222 [TBL] [Abstract][Full Text] [Related]